An EU/International Scope
Our International expertise
Health Care Consultancy is founded and based in the Netherlands. As an expert in the field for over 25 years within the Dutch health care and reimbursement system, HCC is the leading consultant in the field. With the change of the European market and the health care systems being of interest internationally to partners in the US and Asia, HCC has been working for many years with a European and International scope. We are equipped to provide the full coordination of market access projects for multiple European countries and international entrance. Furthermore, we work together with a selected team of European partners that apply the same thorough and dedicated methods as we do.
European Scans
Benelux Group
International Entrance
European cooperation and efficiency among market access consultancies is a key development. From the main basis in the Netherlands, HCC established a European Group consisting of market access partners who are reliable, have vast experience and have similar thorough, client-oriented approach. Our vast experience provides us with the competence to coordinate European market access project and the tools for coordinating and guiding our local colleagues in other European countries.
Why a European Network
While marketing authorization became more centralized...
we envisioned that market access would follow the same path. Indeed, HTA bodies are exchanging assessments or cooperating in common assessments, in which both parties profit from the efficient approach while still letting the Ministries of Health decide themselves based on their local regulations, policies, framework, social values and available health care budget.
1
The need for a network with local specialists
For success and local implementation, local specialists are needed. The local country specific aspects need to be understood to achieve market access and to implement the actual marketing of the medicines within local stakeholder systems.
2
International Entrance
HCC has worked with international clients from the US and Asia on market entrance in Europe or vice-versa. In working with our clients...
High Quality
We are a leading firm in providing value to our customers. Each member of our team has at least 5 years of legal experience.
Good Support
Our managers are always ready to answer your questions. You can call us at the weekends and at night.
Individual Approach
Our company works according to the principle of individual approach to every client.
Intensely Focused
We use a unique technique that allows us to better focus on our clients' problems.
European SCAN
A specialized expert team is equipped to perform a European SCAN to identify key issues in the market access of new products or therapies throughout Europe. We analyze facts with three levels: medical, disease and reimbursement, in order to find the optimal strategy and legal facts and stakeholder analysis are part of this analysis. Though some issues may be facilitated on a corporate level, other issues need a local approach. Together with our local partners we provide strategies and road maps as well as full service local execution of market access projects.
We are equipped to provide the full coordination of market access projects for multiple European countries, working together with a selected team of European partners that apply the same thorough and dedicated methods as we do. Among the European partners are Belgium, Germany, Italy, France, Spain, the United Kingdom/Scotland, Portugal, Scandinavia, Austria and Switzerland.
Recent Scan
We matched the market access strategies and outcomes in three countries for a new product in development for breast cancer. We learned that, though the clinical data set was similar, the health authorities had different considerations and made different decisions based on market access.
We are equipped to provide the full coordination of market access projects for multiple European countries, working together with a selected team of European partners that apply the same thorough and dedicated methods as we do. Among the European partners are Belgium, Germany, Italy, France, Spain, the United Kingdom/Scotland, Portugal, Scandinavia, Austria and Switzerland.
Recent Scan
We matched the market access strategies and outcomes in three countries for a new product in development for breast cancer. We learned that, though the clinical data set was similar, the health authorities had different considerations and made different decisions based on market access.
Local Dutch-Beglian Full Service Consultancy
Our Dutch-Belgian Group consists of a diversity of partners involved in the local Dutch-Belgian market access chain, varying from pharmaceutical development, registration, reimbursement procedures, stakeholder management (early access programs – marketing support after marketing authorization), economic evaluation, budget impact models, interim distribution of medicines and pharmacovigilance.
On demand, our clients make use of these market access chain options. The Dutch-Belgian Group also enables easy switching to additional services without losing time and effort in seeking the right consultancy partner. We know upfront the quality and performance of our partners. Our partners are reliable, have vast experience and have similar thorough, client-oriented approaches in their project performances.
RECENT JOINT-PROJECTS
On demand, our clients make use of these market access chain options. The Dutch-Belgian Group also enables easy switching to additional services without losing time and effort in seeking the right consultancy partner. We know upfront the quality and performance of our partners. Our partners are reliable, have vast experience and have similar thorough, client-oriented approaches in their project performances.
RECENT JOINT-PROJECTS
- A strategic analysis was coordinated for the Netherlands and Belgium on a new type of medicine, an ATMP.
- Efficient reimbursement-dossier-writing for the Netherlands and Belgium by discounting overlapping work.
International
A specialized expert team is equipped to perform a European SCAN to identify key issues in the market access of new products or therapies throughout Europe. We analyze facts with three levels: medical, disease and reimbursement, in order to find the optimal strategy and legal facts and stakeholder analysis are part of this analysis. Though some issues may be facilitated on a corporate level, other issues need a local approach. Together with our local partners we provide strategies and road maps as well as full service local execution of market access projects.
